Jessica A Harper1, Charles South1, Madhukar H Trivedi1, Marisa S Toups2. 1. Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States. 2. Psychiatry, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, United States. Electronic address: marisa.toups@austin.utexas.edu.
Abstract
OBJECTIVE: To determine whether depressed or anxious patients experience greater affective change than mentally healthy individuals following influenza vaccination. METHODS: Participants (n=112) completed the Positive and Negative Affect Schedule (PANAS) before influenza vaccination and 1-2days post-vaccination (M=32.3h). Pre- and post-vaccination PANAS scores were compared using two-tailed, paired-samples t-tests. Change in positive affect between participants with depression or anxiety and those without was compared using two-way ANOVA. Follow up positive affect was further examined using multiple linear regression. RESULTS: Positive affect decreased following vaccination (M=2.18, 95% CI [1.07, 3.29], t(111)=3.89, p<0.001) for all participants and was more pronounced for those with anxiety or depression (F(1, 110)=7.51, p=0.009). Similarly, predicted follow up affect score was higher for those without a mental health conditions (β=3.67, 95% CI [1.18, 6.16], t(103)=2.92, p=0.004). CONCLUSIONS: These data suggest that influenza vaccine has a greater effect on affect in patients with depression and anxiety than in mentally healthy individuals. This effect was focused on positive affect, suggesting that influenza vaccine induced inflammation may be best suited to examine alterations in positive affect and positive valence systems.
OBJECTIVE: To determine whether depressed or anxiouspatients experience greater affective change than mentally healthy individuals following influenza vaccination. METHODS:Participants (n=112) completed the Positive and Negative Affect Schedule (PANAS) before influenza vaccination and 1-2days post-vaccination (M=32.3h). Pre- and post-vaccination PANAS scores were compared using two-tailed, paired-samples t-tests. Change in positive affect between participants with depression or anxiety and those without was compared using two-way ANOVA. Follow up positive affect was further examined using multiple linear regression. RESULTS: Positive affect decreased following vaccination (M=2.18, 95% CI [1.07, 3.29], t(111)=3.89, p<0.001) for all participants and was more pronounced for those with anxiety or depression (F(1, 110)=7.51, p=0.009). Similarly, predicted follow up affect score was higher for those without a mental health conditions (β=3.67, 95% CI [1.18, 6.16], t(103)=2.92, p=0.004). CONCLUSIONS: These data suggest that influenza vaccine has a greater effect on affect in patients with depression and anxiety than in mentally healthy individuals. This effect was focused on positive affect, suggesting that influenza vaccine induced inflammation may be best suited to examine alterations in positive affect and positive valence systems.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Mats Lekander; Bianka Karshikoff; Emilia Johansson; Anne Soop; Peter Fransson; Johan N Lundström; Anna Andreasson; Martin Ingvar; Predrag Petrovic; John Axelsson; Gustav Nilsonne Journal: Brain Behav Immun Date: 2015-12-28 Impact factor: 7.217
Authors: Rudolf Uher; Katherine E Tansey; Tracy Dew; Wolfgang Maier; Ole Mors; Joanna Hauser; Mojca Zvezdana Dernovsek; Neven Henigsberg; Daniel Souery; Anne Farmer; Peter McGuffin Journal: Am J Psychiatry Date: 2014-10-31 Impact factor: 18.112
Authors: Neil A Harrison; Lena Brydon; Cicely Walker; Marcus A Gray; Andrew Steptoe; Hugo D Critchley Journal: Biol Psychiatry Date: 2009-05-07 Impact factor: 13.382
Authors: Ann L Sharpley; Charlotte M Cooper; Clare Williams; Beata R Godlewska; Philip J Cowen Journal: Psychopharmacology (Berl) Date: 2016-08-09 Impact factor: 4.530
Authors: Frederike T Fellendorf; Nina Bonkat; Martina Platzer; Elena Schönthaler; Michaela Ratzenhofer; Susanne A Bengesser; Nina Dalkner; Eva Z Reininghaus Journal: Vaccine X Date: 2022-06-20